U.S. Health Care Policy

Members of ICCR believe that health care is a human right that should be affordable and accessible to all, especially the economically poor and vulnerable. We all must work together to reduce health care costs and further extend coverage. We are convinced the Affordable Care Act (ACA) has been a strong foundation on which to build a more humane world.

The ACA was largely responsible for extending health care coverage to over 20 million previously uninsured Americans – by any standard a remarkable accomplishment that should be celebrated. While we know there is still work to be done, particularly in controlling costs, we urge Congress and the administration to work with key stakeholders to improve the law rather than un-do the significant progress that has been made. 

ICCR members pressed health insurers and large employers to help ensure the passage of ACA and the implementation of robust insurance exchanges.

Featured ICCR Initiatives

Challenging Pharmaceutical Industry LobbyingPharmaceutical companies, health insurers, and medical device manufacturers lobby heavily on issues related to health care, donating significant and often undisclosed sums to political candidates, parties and PACs that in turn, promote public policy and legislation that protects their interests. This flood of corporate money is just one of the legacies of the Supreme Court’s 2010 Citizens United decision. 

Most pharmaceutical companies are also members of industry groups like the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Industry Organization (“BIO”). PhRMA and its member companies spent $40 million lobbying Congress to prevent the passage of the Affordable Care Act.  Many drug companies are also members of the conservative model legislation group the American Legislative Exchange Council (ALEC). ALEC has sought to privatize both Medicare and Medicaid, and repeal important laws that would expand access to health care.  

ICCR members have filed resolutions with Abbvie and Vertex Pharmaceuticals calling for greater transparency on their lobbying activities. The companies receiving resolutions are:

Featured Resources

ICCR's Statement of Principles and Recommended Practices for Corporations on Domestic Health Issues

Vertex at Odds with Religious Investors over Lobbying Disclosures


Jimmy Kimmel Reveals Details of His Son’s Birth & Heart Disease

Sign Up for our eNewsletter

* indicates required